Background: Mortality from inhalational anthrax during the 2001 US attack was substantially
lower than that reported historically. Purpose: To systematically review all published …

Bacillus anthracis infection is rare in developed countries. However, recent outbreaks in the
United States and Europe and the potential use of the bacteria for bioterrorism have focused …

Background Cutaneous anthrax accounts for approximately 95% of anthrax cases
worldwide. About 24% of untreated patients die, and many cases are complicated by …

In 2014, CDC published updated guidelines for the prevention and treatment of anthrax
(Hendricks KA, Wright ME, Shadomy SV, et al. Centers for Disease Control and Prevention …

In the minds of many critical care physicians, particularly those new to the profession,
biowarfare and bioterrorism may seem a product of the unrest in the world punctuated by the …

Inhalational anthrax is a life‐threatening infectious disease of considerable concern,
especially as a potential bioterrorism agent. Progress is gradually being made towards …

Late-stage anthrax infections are characterized by dysregulated immune responses and
hematogenous spread of Bacillus anthracis, leading to extreme bacteremia, sepsis, multiple …

A portable arc-seeded microwave plasma torch running stably with airflow is described and
applied for the decontamination of biological warfare agents. Emission spectroscopy of the …

Expanding identification of potentially protective subunit antigens and correlates of
protection has provided a basis for the introduction of safer vaccines. Despite encouraging …

Vascular dysfunction has been reported in human cases of anthrax, in mammalian models
of Bacillus anthracis, and in animals injected with anthrax toxin proteins. To examine anthrax …